ABBY LAUER: Open Payments
NPI 1902339294 · NEWPORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 38 payments from 11 companies in 2025. Trend: 2023 $1,753 · 2024 $1,573 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $213 |
| ABBVIE INC. | 10 | $154 |
| Novo Nordisk Inc | 5 | $95 |
| Astellas Pharma US Inc | 3 | $68 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Exact Sciences Corporation | 3 | $55 |
| PFIZER INC. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Amgen Inc. | 2 | $33 |
| Abbott Laboratories | 1 | $16 |
Products named: ZEPBOUND, VRAYLAR, Veozah, JARDIANCE, Auvelity, The Cologuard Plus Collection Kit, Wegovy, MOUNJARO.
Industry payments across KY — which companies pay providers there.
